site stats

Certara press release

WebApr 10, 2024 · PRINCETON, N.J., April 10, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release … WebAug 5, 2024 · Total revenue for the second quarter of 2024 was $70.1 million, representing year-over-year growth of 15%. The revenue growth was driven by both technology-driven services and software licenses and subscriptions. Total cost of revenue for the second quarter of 2024 was $27.5 million, an increase from $20.6 million in the second quarter of …

Certara Announces Proposed Public Offering of Common Stock

WebSep 1, 2024 · September 1, 2024. PRINCETON, N.J.—September 1, 2024 . Certara, the global leader in biosimulation, today announced changes to its board of directors, which took effect August 26, 2024. After successfully transitioning the leadership of Certara to Chief Executive Officer William Feehery, Edmundo Muniz has decided to step down from the … WebApr 5, 2024 · d3 Medicine and the Defence Science and Technology (DST) Group will review the country’s medical countermeasures product R&D skills and infrastructure . PRINCETON, NJ – Apr. 5. 2024 – Certara ®, the leading provider of decision support technology and consulting services for optimizing drug development and improving … clifford leafs https://tywrites.com

Certara Reports Fourth Quarter and Full Year 2024 …

WebApr 10, 2024 · PRINCETON, N.J., April 10, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of ... WebSep 3, 2024 · September 3, 2024. PRINCETON, N.J.—September 3, 2024. Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering … WebMay 17, 2024 · PRINCETON, N.J.—May 17, 2024. Certara, Inc, (Nasdaq: CERT), the global leader in biosimulation, announced the appointments of four executives to its growing model-informed drug development team: Dr. Matt Zierhut as Vice President, Model-Based Meta-Analysis, Dr. James Dunyak as Senior Director, Biostatistics and Data … clifford l boggs of irondale oh

Certara to Report First Quarter 2024 Financial Results on May 8th, …

Category:Certara to Report First Quarter 2024 Financial Results on May 8th, …

Tags:Certara press release

Certara press release

Certara to Report First Quarter 2024 Financial Results on …

WebDec 13, 2024 · PRINCETON, N.J., Dec. 13, 2024 — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the feature release of Pinnacle 21 Enterprise 5.1.0, which updates the Company’s flagship software for preparing clinical trial data for biosimulation and regulatory submission. “With today’s announcement, we are just ... WebAug 11, 2014 · Certara’s solutions, which span the discovery, preclinical and clinical stages of drug development, enable data-driven decisions, leading to more precisely designed trials with a reduced risk of failure and improved subject safety. Certara Contact: Teresa A. Bradford, 919-852-4644 Senior Director, Marketing [email protected]. …

Certara press release

Did you know?

WebMar 4, 2024 · Certara completed an initial public offering of 14.6 million shares, raising $316.3 million in net proceeds to the Company. ... This press release contains certain statements that constitute forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, with respect to ... WebMar 1, 2024 · PRINCETON, N.J. , Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release …

WebDec 3, 2024 · PRINCETON, NJ.—. December 3, 2024 – Certara, Inc. (“Certara”) today announced the launch of its initial public offering of 24,390,000 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 14,630,000 shares of common stock and certain selling ... WebMar 7, 2024 · Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel drugs in lieu of conducting clinical studies. PRINCETON, N.J.— March 7, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Simulator Version 22, which includes new capabilities and updated …

WebApr 10, 2024 · PRINCETON, N.J., April 10, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release … WebSep 7, 2016 · It is committed to delivering impactful healthcare solutions through developing and executing value-focused drug development programs. For more information, visit www.d3medicine.com. Certara Contact: Ellen Leinfuss, 609-216-9586. Chief Marketing Officer. Media Contact: Lisa Osborne, 206-992-5245. Rana Healthcare Solutions.

Web2 days ago · Press Release Computational Biology Market growth, trends, Top Key Players, and Forecasts by 2029 – Chemical Computing,Accelrys,Certara,Compugen Published: …

Web2 days ago · Press Release Computational Biology Market growth, trends, Top Key Players, and Forecasts by 2029 – Chemical Computing,Accelrys,Certara,Compugen Published: April 12, 2024 at 6:38 a.m. ET board rowingWebMay 16, 2024 · May 16, 2024. PRINCETON, NJ – May 16, 2024 – Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced today that it has appointed Dr. William F. Feehery as its new Chief Executive Officer (CEO) and a member of the Certara Board of Directors, … clifford lax businessWebApr 10, 2024 · PRINCETON, N.J., April 10, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release … clifford law offices p.cWebApr 10, 2024 · PRINCETON, N.J., April 10, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in biosimulation, today announced that it will release … clifford learning activities oldgamesdownloadWebMar 1, 2024 · News Releases. Certara to Report First Quarter 2024 Financial Results on May 8th, 2024 and Participate in the BofA Securities 2024 Healthcare Conference. Apr … board rrdboar druid hearthstoneWebDec 19, 2013 · December 19, 2013. NEW YORK, NY- Dec. 19, 2013 – Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market healthcare and specialty industrial companies, announced today the acquisition of Certara, the leading provider of model-based drug development and data analytics software and … clifford leach